tions in the cholinergic system of brain stem neurons in a mouse model of Rett syndrome. Am J Physiol Cell Physiol 307: C508 -C520, 2014. First published July 9, 2014; doi:10.1152/ajpcell.00035.2014.-Rett syndrome is an autism-spectrum disorder resulting from mutations to the X-linked gene, methyl-CpG binding protein 2 (MeCP2), which causes abnormalities in many systems. It is possible that the body may develop certain compensatory mechanisms to alleviate the abnormalities. The norepinephrine system originating mainly in the locus coeruleus (LC) is defective in Rett syndrome and Mecp2-null mice. LC neurons are subject to modulation by GABA, glutamate, and acetylcholine (ACh), providing an ideal system to test the compensatory hypothesis. Here we show evidence for potential compensatory modulation of LC neurons by post-and presynaptic ACh inputs. We found that the postsynaptic currents of nicotinic ACh receptors (nAChR) were smaller in amplitude and longer in decay time in the Mecp2-null mice than in the wild type. Single-cell PCR analysis showed a decrease in the expression of ␣3-, ␣4-, ␣7-, and ␤3-subunits and an increase in the ␣5-and ␣6-subunits in the mutant mice. The ␣5-subunit was present in many of the LC neurons with slow-decay nAChR currents. The nicotinic modulation of spontaneous GABAA-ergic inhibitory postsynaptic currents in LC neurons was enhanced in Mecp2-null mice. In contrast, the nAChR manipulation of glutamatergic input to LC neurons was unaffected in both groups of mice. Our current-clamp studies showed that the modulation of LC neurons by ACh input was reduced moderately in Mecp2-null mice, despite the major decrease in nAChR currents, suggesting possible compensatory processes may take place, thus reducing the defects to a lesser extent in LC neurons. acetylcholine; nicotinic acetylcholine receptor; compensatory mechanisms; locus coeruleus; Mecp2; Rett syndrome RETT SYNDROME (RTT) IS AN autism-spectrum disorder caused by mutations to the X-linked gene, methyl-CpG binding protein 2 (MeCP2) (60). The MeCP2 protein regulates transcription by binding to methylated DNA (29). Knockout of this gene in mouse models leads to neurodevelopmental abnormalities, such as improper dendritic formation (9, 17, 44), impaired synaptic transmission (9, 16, 52), and defective neurotransmitter-synthesizing enzyme expression (15, 70), all of which resemble symptoms of RTT and may underlie the dysfunctional signaling between neurons.
RETT SYNDROME (RTT) IS AN autism-spectrum disorder caused by mutations to the X-linked gene, methyl-CpG binding protein 2 (MeCP2) (60) . The MeCP2 protein regulates transcription by binding to methylated DNA (29) . Knockout of this gene in mouse models leads to neurodevelopmental abnormalities, such as improper dendritic formation (9, 17, 44) , impaired synaptic transmission (9, 16, 52) , and defective neurotransmitter-synthesizing enzyme expression (15, 70) , all of which resemble symptoms of RTT and may underlie the dysfunctional signaling between neurons.
People with RTT have defects in autonomic functions and brain stem neuromodulatory systems. Norepinephrine (NE) is a major neuromodulator in the central nervous system (CNS), which acts on breathing (56 -58) , cognition (6, 25, 41, 55) , motor movement, pain (7, 8, 12, 65) , and paradoxical sleep (14, 23, 46, 53) . The NE concentration is low in RTT patients and mouse models of RTT (47, 50, 73, 74) . Application of desipramine, a NE reuptake blocker, ameliorates the breathing problems (66, 69) , further suggesting that the NE-ergic system plays a role in the Mecp2-null phenotype. NE-synthesizing neurons are found mainly in the locus coeruleus (LC) and project throughout the CNS. The NE deficiency appears to result from inadequate expression of tyrosine hydroxylase (TH) and dopamine-␤-hydroxylase in LC neurons of Mecp2 Ϫ/Y mice (70) . Other problems that may contribute to low NE include smaller cell size, defects in intrinsic membrane properties, and a decrease in CO 2 chemosensitivity (54, 69) . Recent studies have shown that defects in presynaptic modulation may affect normal LC neuronal activity as well. The GABA input to the LC is decreased with reduced inhibitory postsynaptic current (IPSC) frequency and amplitude (32) . Also, as opposed to 1-to 2-wk-old Mecp2 Ϫ/Y mice, the allopregnanolone modulation of GABA A receptors in 3-wk-old Mecp2 Ϫ/Y mice is reduced, which is consistent with the onset time of RTT-like symptoms in these mice (33) . Other studies indicate that glutamic acid decarboxylase (GAD), the enzyme responsible for GABA production, is downregulated, leading to less quantal release of GABA (15) . Also, blocking of the GABA transporter results in higher synaptic GABA levels, and RTT breathing symptoms are alleviated (1) . Lastly, when the Mecp2 gene is knocked out of the GABAergic neurons only, RTT-like symptoms are apparent (15) . Therefore, defects in NE-ergic and GABAergic signaling systems contribute to the development of RTT symptoms.
A common link between the NE-ergic and GABAergic systems is the cholinergic system. Through nicotinic acetylcholine (ACh) receptors (nAChR), TH and GAD expressions levels are regulated by the cholinergic system. The GAD expression levels are increased by the activation of ␣ 4 ␤ 2 -receptors, causing phosphorylation of MeCP2 and release from DNA in cortical GABAergic neurons (38) . Less is known about the mechanism, but the TH expression levels are increased by activation of nAChRs in the LC (45) , and the activation of ␣ 7 -receptors in heterologous expression systems upregulates TH and dopamine-␤-hydroxylase expression (28) . The loss of cholinergic neurons (61) and a decline in activity of choline acetyltransferase, an enzyme for ACh biosynthesis (62) , impairs cholinergic signaling. The dysregulation of the cholinergic system is believed to underlie the downregulation of the enzymes for GABA and NE biosynthesis.
These three systems are intimately linked in transitions between sleep states. During rapid eye movement (REM) sleep, cholinergic neuron activity is increased (for a full review, see Ref. 46) . In brief, ACh silences LC neurons through GABAergic input during REM sleep. LC neurons eventually escape this GABA-mediated suppression and, in turn, cease cholinergic neuron firing during non-REM sleep. Children with RTT have sleep abnormalities (13) , which have been impli-cated in affecting cognition and memory (39) . Therefore, determining the modulation of LC neurons by ACh and GABA inputs in the Mecp2 Ϫ/Y mice may provide a basis for treatment in children with RTT.
Previous studies (34, 40, 59 ) and our own preliminary experiments indicated that the major cholinergic modulation of presynaptic GABAergic and LC neurons occurs through nAChRs. The nAChRs are pentameric cation-selective ligandgated channels, which are found throughout the CNS (30, 48) . The nAChRs are abundant in LC neurons, and activation of these receptors leads to an increase in neurotransmitter release in several brain regions, as well as the spinal cord (30, 34) . The subunit composition of nAChRs in the CNS is highly diversified, with major receptors consisting of homomeric ␣ 7 , heteromeric ␣ 4 ␤ 2 , ␣ 6 ␤ 4 , and ␣ 9 ␣ 10 , although other combinations have the potential to form functional channels.
There is a wealth of information on how the cholinergic, NE-ergic, and GABAergic systems work to affect various behaviors. However, it is not known how the signaling between these systems is compromised by neurodevelopmental diseases when all three are affected. Lately, disease models have been emphasized for study of RTT in an attempt to find possible pharmacological therapeutic approaches. However, it is unclear how the widespread defects caused by the Mecp2 disruption affect multiple modulatory systems. We hypothesize that the presynaptic and postsynaptic cholinergic modulation of LC activity is compromised. Using patch-clamp electrophysiology, we studied presynaptic and postsynaptic cholinergic modulation of LC neurons in wild-type (WT) and Mecp2 Ϫ/Y mice. This and single-cell PCR allowed us to determine how changes in nAChR expression altered nicotinic current kinetics in Mecp2 Ϫ/Y mice. Our results suggest that the nicotinic receptor expression in LC and GABAergic neurons is altered to maintain the cholinergic modulation of LC neurons in Mecp2 Ϫ/Y mice. Brain slice preparation. Brain slices were prepared as described previously (20, 68) . In brief, mice were decapitated after deep anesthesia with inhalation of saturated isoflurane. The brain stem was obtained rapidly and placed in an ice-cold, sucrose-rich artificial cerebrospinal fluid (sucrose aCSF) containing (in mM) 200 sucrose, 3 KCl, 2 CaCl 2, 2 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, and 10 D-glucose. The solution was bubbled with 95% O2 and 5% CO2 (pH 7.40). Transverse pontine sections (250 -300 M) containing the LC area were obtained using a vibratome sectioning system. The slices were transferred to normal aCSF in which the sucrose was substituted with 124 mM NaCl, allowed to recover at 33°C for 1 h, and then kept in room temperature before being used for recording. One of the slices was transferred to a recording chamber that was perfused with oxygenated aCSF at a rate of 2 ml/min and maintained at 34°C.
MATERIALS AND METHODS

Animals
Identification of LC neurons.
The LC neurons were identified by 1) their location between the pons and midbrain below the lateral end of the fourth ventricle; 2) their morphological characteristics, as seen under the charge-coupled device camera; and 3) their electrophysiological properties. Only neurons with stable resting membrane potentials more negative than Ϫ40 mV, and action potentials with amplitudes of Ͼ75 mV were used in the studies.
Electrophysiology. Whole cell voltage-clamp and current-clamp studies were performed on cells visualized using a near-infrared charge-coupled device camera. Patch pipettes were pulled with a Sutter pipette puller (model P-97, Novato) with a resistance of 4 -6 M⍀. The internal (pipette) solution for current-clamp and whole cell nAChR current voltage-clamp recordings contained (in mM) 130 potassium-gluconate, 10 KCl, 10 HEPES, 2 Mg-ATP, 0. 3 Na-GTP, and 0. 4 EGTA (pH 7.30). The aCSF solution was applied to the bath, containing (in mM) 124 NaCl, 3 KCl, 1. 3 NaH 2PO4, 2 MgCl2, 10 D-glucose, 26 NaHCO3, 2 CaCl2 (pH 7.40 bubbled with 95% O2 and 5% CO2). The slices were perfused with the external solution continuously with superfusion of 95% O2 and 5% CO2 at 34°C. Whole cell voltage-clamp experiments were performed at a holding potential of Ϫ70 mV. For whole cell nAChR current experiments, the synaptic currents were blocked with the N-methyl-D-aspartate receptor antagonist DL-2-amino-5-phosphonopentanoic acid (10 M), the ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (5 M), the glycine receptor antagonist strychnine (1 M), the GABA A receptor antagonist bicuculline (20 M) , and the voltage-gated sodium channel blocker tetrodotoxin (0.5 M). When ACh was applied, the muscarinic receptor antagonist atropine (10 M) was used. The local perfusion pipette had a resistance of 0.5-1 M⍀, and, just before either 100 M ACh or 100 M nicotine in 1 s and 44 nl with the Nanoject II (Drummond Scientific, Broomall, PA), the perfusion pipette was moved to within 20 -30 m of the cell. Studies were conducted with food coloring to make sure the pipettes did not leak the drug, and to make sure the drug diffused quickly in the bath. Immediately after drug application, the perfusion pipette was removed from the bath. A minimum of 45 min was allowed between each drug treatment to eliminate any desensitization, and no slice was exposed to the drug more than four times. After the current was elicited by the drug, the cell contents were harvested into the patch pipette with negative pressure and dropped into an Eppendorf tube containing 10ϫ RT buffer, RNase-free water, and RNase out (4.5:4.5:1) and then quickly placed in liquid nitrogen until further processing. The cell capacitance was measured at the beginning of the recording, and any recordings where the series resistance changed during the course of the experiment were rejected from further analysis. The internal pipette solution for spontaneous GABA A receptor-mediated IPSC (sIPSC) recordings contained the following (in mM): 50 KCl, 2 MgCl2, 85 CsCl, 2 Mg-ATP, 1 Na-GTP, 10 HEPES (pH 7.30). The external solution consisted of the following (in mM): 130 NaCl, 3. 5 KCl, 1. 25 NaH 2PO4, 1. 5 MgSO4, 10 D-glucose, 24 NaHCO3, 2 CaCl2 (pH 7.40 with 95% O2 and 5% CO2). The sIPSCs were pharmacologically isolated by using 5 M 6-cyano-7-nitroquinoxaline-2,3-dione, 10 M DL-2-amino-5-phosphonopentanoic acid, and 1 M strychnine. The internal pipette solution for glutamatergic spontaneous excitatory postsynaptic currents (sEPSCs) contained the following (in mM): 135 Cs-methanesulfonate, 10 KCl, 1 MgCl 2, 10 HEPES, 4 MgATP, 0.3 NaGTP, and 0.2 NaEGTA. The sEPSCs were isolated using 20 M bicuculline and 1 M strychnine. Recorded signals were amplified with an Axopatch 200B amplifier (Molecular Devices, Union City, CA), digitized at 10 kHz, filtered at 2 kHz, and collected with the Clampex 8.2 data acquisition software (Molecular Devices).
Reverse transcription and single-cell PCR. Reverse transcription of the single-cell contents obtained from LC neurons showing nicotinic currents. The first-strand cDNA synthesis was performed using the high-capacity cDNA reverse transcription kit (Life Technologies, Grand Island, NY) per the manufacturer's instructions. The reverse transcription product was kept at Ϫ20°C until PCR was performed. PCR primers for the target genes were designed with the computer software program primer express (Applied Biosystems) ( Table 1) . PCR product lengths were ϳ200 bp so as to not confuse them with primer dimers. Three microliters of reverse transcription product were loaded into an Eppendorf tube with PCR solution containing 10 l of 5ϫ green GoTaq flexi buffer, 2 l MgCl 2, 1 l of 10 mM dNTP mix, 1 l of 10 mM forward and reverse primers, 0.25 l of GoTaq polymerase, and diluted to 50 l with nuclease-free water. The thermal cycling program was set to the initial denaturation for 5 min at 95°C for one cycle. The denaturation, annealing, extension cycles were done at 95°C for 45 s, 58°C for 45 s, and 72°C for 1 min, respectively, for 35 cycles. A final extension cycle was done at 72°C for 10 min. Three microliters of the PCR reaction were placed into a second PCR tube with the same solution as before. The same cycling protocol was performed as before. Twenty microliters from the second PCR reaction was run on a 2% agarose gel containing ethidium bromide. Gels were imaged using Alpha Innotech Imaging System (Alpha Innotech, Santa Clara, CA). Images were taken normally, and a second with a high background. Presence of receptor subunits in the LC cell was defined by having a band at the correct size, regardless of strength. Cells that had lanes with smearing or possible degradation were eliminated from the experiment. Cells were tested for the glial fibrillary acidic protein transcript for possible glia contamination. Any cells with positive results for glial fibrillary acidic protein were eliminated from decay time analysis.
Data analysis. The electrophysiological data were analyzed with Clampfit 10. 3 software (Molecular Devices) and Mini Analysis Program 6.0.7 software (Synaptosoft). Decay time constants were determined using a single-exponential equation in Clampfit. Data are presented as means Ϯ SE. Statistical analysis of other parameters was performed using the ANOVA, two-tailed Student's t-test or the Mann-Whitney test. Difference was considered significant when P Յ 0.05.
RESULTS
The whole cell nAChR currents were altered in Mecp2
Ϫ/Y mice. LC neurons were studied in brain slices obtained from WT and Mecp2 Ϫ/Y mice. We verified that the neuron was from the LC both visually and electrophysiologically as we did previously (68) . nAChR currents were recorded from the LC neurons after the synaptic input was blocked with DL-2-amino-5-phosphonovaleric acid (10 M), 6,7-dinitroquinoxaline-2,3-dione (5 M), bicuculline (20 M), strychnine (1 M), tetrodotoxin (1 M), and the muscarinic receptor antagonist atropine (10 M). With the membrane potential held at Ϫ70 mV in the voltage-clamp mode, a local application of 100 M ACh (44 nl, in 1 s) to the LC area evoked large inward currents. The currents in the WT animal rose quickly, reached the peak, and decayed rapidly (Fig. 1A) . However, a long-lasting current was observed in Mecp2 Ϫ/Y cells (Fig. 1B) . In comparison, the Ϫ/Y mice than in the WT (68) . With the cell size taken into consideration, we compared the current density between the WT and Mecp2 Ϫ/Y mice, which was Ϫ7.2 Ϯ 1.0 pA/pF (n ϭ 31) and Ϫ4.4 Ϯ 1.4 pA/pF (n ϭ 11), respectively (P Ͻ 0.05; Mann-Whitney test; Fig. 1D ). When we measured the area under the curve, we found that there was no difference between the WT and Mecp2 Ϫ/Y mice (Ϫ202.0 Ϯ 32.4 nA·ms WT vs. Ϫ170.3 Ϯ 101.8 nA·ms; n ϭ 31 and n ϭ 11, respectively; Student's t-test; P Ͼ 0.05; Fig. 1F ). These results suggest that the Mecp2 knockout leads to nAChR currents that are smaller in amplitude but last longer, as shown in the decay time.
Previous studies indicated that atropine, a muscarinic receptor antagonist, may interfere with nAChR activation (75) . Therefore, we verified the ACh results by applying nicotine, a specific nAChR agonist, without any atropine to the LC neuron during patch-clamp recordings. A local application of 100 M nicotine (44 nl, in 1 s) resulted in larger currents in WT than in Mecp2 Ϫ/Y mice (Ϫ122.7 Ϯ 18.7 pA, n ϭ 10 in WT vs. Ϫ41.1 Ϯ 3.1 pA, n ϭ 12 in Mecp2 Ϫ/Y ; P Ͻ 0.001; MannWhitney test; Fig. 2, A-C) . Nicotine elicited similar whole cell current characteristics as ACh. The nicotine current density differed significantly between WT and Mecp2 Ϫ/Y (Ϫ7.7 Ϯ 1.1 pA/pF WT vs. Ϫ2.8 Ϯ 0.2 pA/pF Mecp2 Ϫ/Y ; P Ͻ 0.001; Mann-Whitney test; Fig. 2D ), and the decay time constant was longer in Mecp2 Ϫ/Y mice than in WT mice (2.7 Ϯ 1.1 s, n ϭ Ϫ/Y ; P Ͻ 0.001; Mann-Whitney test; Fig. 2E ). The area was not different either (Ϫ150.9 Ϯ 34.6 nA·ms vs. Ϫ107.09 Ϯ 34.7 nA·ms, n ϭ 10 and n ϭ 17, respectively; Student's t-test; P Ͼ 0.05; Fig. 2F) .
Alterations in nAChR expression and decay time may be related. The changes in the amplitude and kinetics of nAChR currents may be due to the alterations of the receptor species. Therefore, we analyzed the expression of nAChR subunits (␣ 2-7 , ␣ 9 , ␣ 10 , and ␤ 2-4 ) in each LC neuron with distinct nAChR currents using the single-cell PCR assay. WT neurons expressed various combinations of ␣ 3 -, ␣ 4 -, ␣ 5 -, ␣ 6 -, ␣ 7 -, ␣ 9 -, ␤ 2 -, and ␤ 3 -transcripts, although they were not expressed in every neuron tested. Figure 3A shows the expression of ␣ 3 , ␣ 4 , ␣ 6 , ␣ 7 , ␣ 9 , ␤ 2 , and ␤ 3 in one LC neuron, whereas another cell expressed ␣ 3 , ␣ 7 , ␣ 9 , and ␤ 3 (Fig. 3B) . Of the 19 WT cells tested, the ␣ 7 -and ␣ 9 -transcripts were expressed in 14 and 18 cells, respectively (Fig. 3D) . The ␣ 5 -and ␣ 6 -subunits were expressed in three and one cell, respectively. The ␣ 3 -transcript was found in nine cells, and the ␣ 4 -subunit was found in six cells. The ␤ 3 -subunit was seen in 16 neurons, the ␤ 2 -subunit was only expressed in 2 cells, and the ␤ 4 -subunit was not expressed in any cell tested (Table 2) .
LC neurons from Mecp2 Ϫ/Y mice expressed only ␣ 3 -, ␣ 5 -, ␣ 6 -, ␣ 9 -, and ␤ 3 -subunits. The ␣ 4 and ␣ 7 , seen in most WT neurons, were not found in any of the 18 cells tested. Although the ␤ 3 -subunit was found in Mecp2 Ϫ/Y neurons (Fig. 3C ), there was a major reduction in its expression, which was seen in 8 of ; n ϭ 19 WT and n ϭ 18 Mecp2 Ϫ/Y ; P Ͻ 0.05; Mann-Whitney; Fig. 4A ). Based on the single-cell PCR data and the fact that others have noticed the interchangeability of these subunits (21, 27), suggesting they may serve similar functions, the ␣ 5 -and ␤ 3 -subunits were likely candidates for the decay time changes. We compared decay times of cells that expressed either the ␣ 5 -or ␤ 3 -subunits, but not both.
To do this, we omitted four cells from the group that contained ␣ 9 only and two cells that expressed both ␣ 5 and ␤ 3 . When the ␣ 5 -subunit was expressed, the decay time was 10.7 Ϯ 2.5 s (n ϭ 6; Fig. 4B ). When the ␤ 3 -subunit was present in WT and Mecp2 Ϫ/Y mice without ␣ 5 , the time constants were similar (2.8 Ϯ 0.5 s WT vs. 4.23 Ϯ 1.1 s Mecp2 Ϫ/Y ; n ϭ 14 WT and n ϭ 6 Mecp2 Ϫ/Y ; Student's t-test; P Ͼ 0.3). When all three groups were compared with each other using a one-way ANOVA, significant differences were found between the Mecp2 Ϫ/Y group expressing the ␣ 5 -subunit and both ␤ 3 -expressing groups (P Ͻ 0.01). It is important to note that we also compared the current amplitudes in the Mecp2 Ϫ/Y mice for when ␣ 5 and ␤ 3 were present or not and found that there was no significant difference (data not shown).
The Mecp2 Ϫ/Y mice had populations of cells that only contained combinations of either ␣ 9 ␤ 3 or ␣ 9 ␣ 5 . By removing one cell that expressed the ␣ 9 , ␣ 3 , and ␤ 3 and another cell that expressed the ␣ 5 , ␣ 6 , and ␣ 9 , we were able to take advantage of the expression patterns in these neurons to determine whether ␣ 5 and ␤ 3 play a role in decay time kinetics. We compared the decay time constants of these populations and found that the ␣ 9 ␤ 3 -expressing neurons had a shorter decay time constant than the ␣ 9 ␣ 5 -containing neurons (3.9 Ϯ 1.2 s ␣ 9 ␤ 3 vs. 12.2 Ϯ 2.5 s ␣ 9 ␣ 5 ; P Ͻ 0.05; n ϭ 5 and n ϭ 5, respectively; Fig. 4C ).
We also compared the contributions of the other subunits that were downregulated in the Mecp2 Ϫ/Y mice. The ␣ 3 , ␣ 4 , and ␣ 7 were downregulated in the Mecp2 knockout, which may contribute to the decrease in current amplitude and the increase in the decay time. Since these subunits were largely not present in the Mecp2 Ϫ/Y mice, we compared the current amplitudes and decay times when the subunit was present or not in WT mice only. The presence of the ␣ 3 -and ␣ 4 -subunits did not have any significant effect on the amplitude or decay time of the current (data not shown). However, alteration in the nAChR current amplitude was seen, depending on the presence of the ␣ 7 -subunit (Ϫ134.6 Ϯ 19.0 pA ␣ 7 vs. Ϫ67.9 Ϯ 9.9 pA no ␣ 7 ; n ϭ 14 and n ϭ 5, respectively; Student's t-test; P Ͻ 0.01; Fig. 5A ). The decay was longer when ␣ 7 was not present (2.8 Ϯ 0.6 s ␣ 7 vs. 5.7 Ϯ 1.6 s no ␣ 7 ; n ϭ 14 and n ϭ 5, respectively; Student's t-test; P Ͻ 0.05; Fig. 5B ). By teasing apart the data to determine the contribution of the receptor subunits to the current amplitude and decay time, our data suggest that the lack of ␣ 7 contributes mostly to the decrease in the current amplitude in Mecp2 Ϫ/Y mice and has some effect on the longer decay time, while the ␤ 3 -subunit contributes to the shorter decay time constant, and the ␣ 5 confers a longer decay time constant to the nAChR current. Therefore, the change of the subunit expression in the Mecp2 Ϫ/Y mice appears to cause alterations in the nAChR currents. The increase in the proportion of cells with the ␣ 5 in Mecp2 Ϫ/Y mice compared with WT and the decrease in the ␤ 3 -subunit proportion allows for the decay time to be increased in the knockout mice.
GABAergic input but not glutamatergic input was augmented by nicotinic presynaptic modulation in Mecp2
Ϫ/Y mice. The nAChRs modulate GABA and glutamate release in several brain areas. We chose to study sIPSCs of GABA A and glutamate receptors, as they are the prominent synaptic currents in the CNS and are known to be dysregulated in RTT. To understand the presynaptic modulation of LC neurons by ACh in Mecp2 Ϫ/Y mice, we performed whole cell patch clamp in the LC neurons and bath-applied the nAChR agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP; 10 M). The GABA A sIPSC frequency was augmented by the DMPP application in LC neurons of WT and Mecp2 Ϫ/Y mice, which was more obvious in the Mecp2 Ϫ/Y mice by 189.0 Ϯ 10.1% (n ϭ 8) than in the WT by 147.1 Ϯ 7.0% (n ϭ 8) (P Ͻ 0.01, Mann-Whitney test; Fig. 6, A and B) . The sIPSC amplitude was augmented in WT and Mecp2 Ϫ/Y mice, to a lesser degree though (110.5 Ϯ 7.6% WT vs. 105.4 Ϯ 6.7% Mecp2 Ϫ/Y ; Mann-Whitney; P Ͼ 0.05; n ϭ 8 for both; Fig. 6, A and C) . This led to a shift of the interevent interval cumulative probability to the higher frequency, which was greater in the Mecp2 Ϫ/Y mice without an evident shift in the amplitude cumulative probability (Fig. 6, E  and F) . Consistently, the application of the nAChR antagonist mecamylamine (30 M) caused a reduction in GABA A -mediated sIPSC frequency in WT mice to 78.2 Ϯ 4.8% (n ϭ 11, Fig. 7, A and C) . There was little change in the amplitude (96.4 Ϯ 3.5%; n ϭ 11 in WT; Fig. 7D ). The effect of mecamylamine on nicotinic modulation of GABAergic sIPSC frequency was lowered to 62.6 Ϯ 4.5% (n ϭ 11) in Mecp2 Ϫ/Y neurons (7, B and C), and the amplitude was unchanged at 102.3 Ϯ 4.0% (n ϭ 17; Fig. 7D ). The shift to the lower frequency of interevent interval cumulative probability was larger in the Mecp2 Ϫ/Y mice than in WT (Fig. 7E) . There was no shift in the amplitude cumulative probability (Fig. 7F) . The inhibition of sIPSC frequency by mecamylamine was significantly greater in Mecp2 Ϫ/Y mice than that in the WT (P Ͻ 0.01; Mann-Whitney), whereas the amplitude difference was not (P Ͼ 0.05; Mann-Whitney).
A decrease in MeCP2 expression levels dysregulates the excitatory synaptic strength by reducing the number of glutamatergic synapses and by interrupting synaptic scaling mechanisms (10, 36) . Also, ␣ 7 -and ␤ 2 -subunits are instrumental in synapse and spine formation (36, 37) . Because of this, we tested whether the glutamatergic input to the LC is altered in Mecp2 ; n ϭ 11 and n ϭ 5, respectively). We found that there was an increase in frequency and amplitude after the DMPP application. This in- , n ϭ 11 and n ϭ 5, respectively; P Ͼ 0.05).
Cholinergic modulation of LC neuronal activity was sustained in Mecp2
Ϫ/Y mice, despite a large decrease in nAChR currents. To determine the consequences of the cholinergic modulatory dysfunction on the LC neuron firing activity, we performed current clamp in WT and Mecp2 Ϫ/Y mice. Bathapplication of DMPP (10 M) increased the activity of LC neurons in WT mice from 4.5 Ϯ 0.4 Hz to 6.7 Ϯ 0.6 Hz (n ϭ 11; P Ͻ 0.001; Student's t-test. Fig. 8, A and C) , a 48% increase (Fig. 8E) . The input resistance was decreased from 424.8 Ϯ 34.1 M⍀ to 336.0 Ϯ 27.5 M⍀ (n ϭ 11; P Ͻ 0.001; Student's t-test; Fig. 8A ), a 20% decrease (Fig. 8F) , and the neurons were depolarized from Ϫ45.9 Ϯ 1.1 mV to Ϫ44.6 Ϯ 1.2 mV (n ϭ 11; P Ͼ 0.05; Student's t-test; Fig. 8G ). We also performed the same experiment by applying 50 M ACh (data not shown). There was very little difference between the ACh and DMPP treatments (ϳ6%). This suggests very little muscarinic receptor influence on LC neuron postsynaptic properties. The DMPP treatment raised the LC neuronal firing activity in Mecp2 Ϫ/Y mice from 3.8 Ϯ 0.5 Hz to 5.2 Ϯ 0.7 Hz (n ϭ 11; P Ͻ 0.001; Student's t-test; Fig. 8, B and D) , a 37% increase (Fig. 8E) , and reduced the input resistance from 547.5 Ϯ 67.7 M⍀ to 454.4 Ϯ 54.8 M⍀ (n ϭ 11; P Ͻ 0.001; Student's t-test; Fig. 8B ), a 17% decrease (Fig. 8F) . The neuron was depolarized from Ϫ48.5 Ϯ 2.2 mV to Ϫ46.3 Ϯ 2.5 mV (n ϭ 11; P Ͼ 0.05; Student's t-test; Fig. 8G ). When the changes in firing frequency, input resistance, and membrane potential were compared using the Mann-Whitney test, there were no differences between the WT and Mecp2 Ϫ/Y mice (Fig.  8, E-G) .
DISCUSSION
In the present study, we found that the postsynaptic nAChR currents in LC neurons of Mecp2 Ϫ/Y mice is altered. This alteration in the current amplitude and decay time constant is likely due to changes in expression of specific nAChR subunits, namely the ␣ 5 , ␤ 3 , and ␣ 7 . We also found that the nAChR modulation of GABA input to the LC is enhanced in Mecp2 Ϫ/Y mice, whereas the cholinergic modulation of glutamatergic input is unchanged.
Changes in nAChR subunit expression may be responsible for altered current. Previous studies have shown that nAChRmediated current characteristics can be attributed to the expression of the subunits by a particular cell. Many have used pharmacological agents and molecular techniques to block different subunits and thus alter the amplitude and decay time constant of the current (2) (3) (4) 49) . This line of research leads one to some generalizations of the subunit contribution to the nAChR current. The ␣ 7 -subunit is usually associated with a large transient peak, whereas the ␣ 3 -and ␣ 4 -subunits are associated with smaller amplitude currents with a longer decay time (24, 35, 71) . In single-channel recordings, the ␣ 5 -subunit increases the mean open time (18) , and the insertion of ␤ 3 can shorten the decay time (11) . WT LC neurons display a variety of nAChR subunits that contribute to different kinetics of an elicited current (34) . Consistent with these findings, we found that these current changes are attributable to changes in subunit expression. The loss of ␣ 7 expression in the Mecp2 Ϫ/Y group seems to underlie the decrease in the current amplitude. When we compared the current amplitudes for when ␣ 7 was present or not in WT mice, the absence of the ␣ 7 -subunit caused a reduction in amplitude that was similar to the Mecp2 Ϫ/Y amplitude. When we compared the decay times to the presence of certain receptor subunits, we found that the ␣ 5 and ␤ 3 seemed to make a large impact on it. The ␣ 5 seemed to confer a long decay time, whereas the ␤ 3 -subunit caused a short decay time. These data seem to suggest that, since the ␣ 3 , ␣ 4 , and ␣ 7 are severely downregulated in the Mecp2 Ϫ/Y mice, there may be direct regulation of their expression by MeCP2 as opposed to the other subunits. The ␤ 3 is downregulated by one-half, which implies that it may be indirectly regulated by MeCP2 or not at all. Consequently, it may be altered by the overall changes in other receptors. Since MeCP2 is a transcription repressor, the loss of function may result in a larger expression of the ␣ 5 -subunit. However, it is still unclear which upstream proteins affect expression of the ␤ 3 -or ␣ 5 -subunits.
Adaptations in LC neurons of Mecp2
Ϫ/Y mice. Maintaining homeostasis is essential for living and adapting to new environments, stimulations, or perturbations. Much work has been done to study homeostatic mechanisms in the nervous systems of normal animals, while much less is known about how the body adapts to disease. The understanding of disease progression requires knowledge of how the system (body) acts to prevent the onset of symptoms or diminish them. However, compensation mechanisms for neuronal dysfunction in disease models have received relatively little attention. It is understandable that, when functional assay results do not show any difference between WT and the knockout, one would assume there is no change in the system. In the case here, we found that the nAChR whole cell currents and receptor expression changed in the Mecp2 Ϫ/Y mice without any cholinergic modulatory deficits to the LC neurons. Our data support the possibility that compensatory mechanisms may be in place to alleviate deficits in neurotransmission found in RTT.
Whether compensatory mechanisms exist in RTT is still elusive. We have found that the Mecp2 knockout leads to a reduction in the nAChR current amplitude, while the decay time of the currents is much longer. The decrease in amplitude is likely mediated by deficient expression of ␣ 7 -subunits. However, it seems that the LC neurons are capable of limiting the effect of the reduction in amplitude by upregulating ␣ 5 in the Mecp2 Ϫ/Y mice. These changes lead to prolonged nAChR currents that appear to maintain postsynaptic modulation of LC neurons. Concerning a difference in the cholinergic facilitation, the firing activity of Mecp2 Ϫ/Y neurons was only 11% smaller ( Fig. 8) than that of the WT, in contrast to ϳ64% deficiency in the postsynaptic nAChR current amplitude (Fig. 2) . Thus these results are consistent with certain endogenous compensatory processes that may exist, allowing LC neurons to significantly diminish the consequences of Mecp2 knockout defects. The question arises, can a current amplitude reduction of ϳ64% result in more than an 11% decrease in LC activity? We feel that it is highly likely. Based on the literature, nAChR activation has several effects on neurons that are consistent with this line of thought. Activation of nAChR increases can induce cell firing from silence. When the ␣ 7 -receptor is blocked, the action potential induction is blocked as well (31) . The firing frequency in area prostrema neurons are increased more with 30 M nicotine than with 10 M. nAChR activation also increases the excitability of these neurons, thus causing an increased response to a depolarizing current (26) . Furthermore, neurons can be depolarized, and the input resistance decreases in a dose-dependent manner (72) . Lastly, we measured the area of the nAChR current by multiplying the current amplitude by the total time. When we compared the WT and Mecp2 Ϫ/Y mice areas, they were not different (Figs. 1F and 2F ). If the current amplitude was reduced without a change in the decay time constant, then the area would be much smaller. Since the total cation charge crossing the membrane would be much less, the changes in membrane potential, input resistance, and firing frequency of LC neurons would be less. Here we do not see that. Therefore, it does seem that the changes in expression of subunits does have some positive effect on the cholinergic modulation of LC neurons. The decrease in ␣ 7 and ␤ 3 may indirectly contribute to the increase in the decay time as well. When we compared decay times based on the presence of ␣ 7 in WT mice, we found that, when no ␣ 7 was present, the decay time was longer. Since no Mecp2 Ϫ/Y mice expressed the ␣ 7 -subunit, it is reasonable to assume the loss of ␣ 7 had some impact on the decay time constant. The impact of the loss of ␤ 3 may be substantial as well. In the two Mecp2 Ϫ/Y cells that contained both ␣ 5 and ␤ 3 , the cells had a short decay time. With this data and the fact that most WT cells with short decay times expressed ␤ 3 , we can assume the ␤ 3 plays a large role in shaping the nAChR current decay. We studied mice at the age at which the neurodevelopmental symptoms of RTT occur. At this age, if the cell is adapting to the loss of the ␣ 7 -subunit by reducing ␤ 3 -expression and increasing ␣ 5 , then there may be a larger variability in the subunit expression here than one would see at older ages. Therefore, other studies should be done to thoroughly examine how the receptor subunit expression changes in LC neurons at different ages in WT and Mecp2
The nAChR modulation of GABAergic inputs to the LC is enhanced in the Mecp2 Ϫ/Y mice. This enhancement is likely caused by an increased sensitivity of the nAChR to DMPP. It is not clear if the increased sensitivity is due to an upregulation of the same receptor subtype, or an alteration in the composition of the nAChR. The ␣ 4 ␤ 2 -, ␣ 7 , and ␣ 6 -containing nAChRs increase release of GABA through different mechanisms in different brain regions (5, 43, 63, 67) . One of these receptor types could mediate the increase in nAChR modulation of GABA release. Our data suggest that alterations in nAChR composition seem to occur in GABAergic neurons. However, an alternative hypothesis is that the ␣ 4 ␤ 2 nAChR, a known regulator of GAD expression, is upregulated to compensate for the low GAD expression in GABA neurons. In this case, the increase in GABA release may be an unintended consequence to the upregulation of the ␣ 4 ␤ 2 . In this second scenario, the disruption of normal MeCP2 function would have to be occurring through a different mechanism than in the LC or at different ages than we were testing.
The adaptations seen here at the neuronal level help to maintain proper modulation of LC neurons. One may make some predictions if these adaptations did not exist or were not compensatory. Due to the reduction in ACh release and subunit expression in animal models for RTT, if there were no compensatory mechanisms in place, the cholinergic modulation of LC neurons and GABA neurons would be much less. Here, we do not see this. We see that the LC modulation is relatively maintained, and cholinergic modulation of GABAergic neurons is enhanced. If the adaptations were independent or linked with no compensatory benefit, then one would predict these values would be similar to a neuron with a nAChR current with a small amplitude and small decay. Thus the cholinergic modulation of LC neurons would be greatly diminished.
In conclusion, our studies demonstrate several potential endogenous mechanisms underlying the avoidance of a total collapse of the LC system due to the Mecp2 knockout. The upregulation of the ␣ 5 -subunit seems to increase the decay time of the whole cell nAChR current in Mecp2 Ϫ/Y mice, thereby reducing the impact of the major decrease in current amplitude by the downregulation of the ␣ 7 -subunit. This compensation seems to maintain some level of cholinergic modulation to the LC neurons. We have also shown that the nAChR modulation of GABA input to the LC is enhanced in Mecp2 Ϫ/Y mice, which appears to compensate for the defects in GABAergic input to LC neurons found previously. We believe that these findings are encouraging, as the information may help the design of a new generation of therapies by targeting possible endogenous compensatory mechanisms.
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